The Chinese experience of TCM treatment for COVID-19 will encounter many obstacles in the US medical system, including the legal restrictions on TCM herbs, the barrier of the hospital system, and some limitations of professional licenses and so on. The overseas community of Chinese medicine expects that clinical research data from China will reach the threshold of evidence-based medicine, and hopes to use the irrefutable demands from the public, by way of exception to open the barriers of the existing Western medical system. In fact, no matter how doctors in Chinese medicine can finally participate, this once-in-a-century pandemic may become an opportunity for overseas TCM development. The author particularly reminds overseas practitioners to pay attention to the changes in medical needs after the pandemic and the real opportunities for Chinese medicine and acupuncture in the management of post pandemic conditions.